Literature DB >> 2119390

Secretory dynamics of growth hormone in an acromegalic patient associated with Graves' disease.

A Shimatsu1, H Murabe, S Sasaki, N Hattori, T Tanoh, H Imura.   

Abstract

The dynamics of GH secretion were investigated in an acromegalic patient with Graves' disease during treatment with antithyroid drugs and radioactive iodine. The mean (+/- SE) basal plasma GH levels were 16.5 +/- 0.9 and 7.8 +/- 0.7 micrograms/L during the hyperthyroid and euthyroid states, respectively. There was a positive correlation (r = 0.902) between basal GH and free T4 levels. Twenty-four-hour plasma GH and urinary GH excretion both increased during the thyrotoxic state. Intravenous administration of TRH induced a marked increase in plasma GH levels during euthyroidism and a modest increase when the patient was hyperthyroid, whereas GH release induced by GH-releasing hormone was not altered by thyroid status. These findings suggest that hyperthyroidism stimulated spontaneous GH secretion from the pituitary adenoma, but inhibited the stimulating effect of TRH.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119390     DOI: 10.1210/jcem-71-4-1059

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Acromegaly and thyroid.

Authors:  Klaus von Werder
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

2.  Growth hormone-secreting pituitary adenoma associated with multiple bone cysts, skin pigmentation and aortitis syndrome.

Authors:  C Ihara; A Shimatsu; H Murabe; K Kataoka; C Kondo; K Nakao
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

3.  Growth hormone and insulin-like growth factor 1 affect the severity of Graves' disease.

Authors:  Alfredo Di Cerbo; Federica Pezzuto; Alessandro Di Cerbo
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.